The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for FibroGen Inc (FGEN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.0432, or 8.16%, to $0.5723. The FibroGen Inc has recorded 77,271 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that FibroGen Reports Third Quarter 2023 Financial Results.
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $0.53 and fluctuated between $0.6298 as its day high and $0.5240 as its day low. The current market capitalization of FibroGen Inc is $52.03M. A total of 1.16 million shares were traded on the day, compared to an average of 4.13M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, FGEN has seen 2 BUY and 8 SELL insider trades, representing the acquisition of 240,000 and the disposition of 12,559 shares. Over the last 12 months, there were 27 BUYs and 70 SELLs from insiders. Insiders purchased 818,485 shares during that period but sold 233,503.
In the most recent transaction, Henderson Jeffrey William sold 2,000 shares of FGEN for 1.03 per share on Sep 01. After the transaction, the Director now owns 28,866 company shares. In a previous transaction on Aug 04, Henderson Jeffrey William sold 2,000 shares at 1.91 per share. FGEN shares that Director owns now total 30,866.
Among the insiders who sold shares, Henderson Jeffrey William disposed of 2,000 shares on Jul 11 at a per-share price of $2.69. This resulted in the Director holding 32,866 shares of FGEN after the transaction. In another insider transaction, Conterno Enrique A sold 1,880 shares at $2.80 per share on Jul 07. Company shares held by the Chief Executive Officer now total 374,722.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for FGEN in the last 3 months, the mean price target is $0.55 with high estimates of $0.60 and low estimates of $0.50. In terms of 52-week highs and lows, FGEN has a high of $25.69 and a low of $0.33.
As of this writing, FGEN has an earnings estimate of -$0.44 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.42 per share and a lower estimate of -$0.46. The company reported an EPS of -$0.9 in the last quarter, which was -28.60% lower than expectations of -$0.7.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. FGEN’s latest balance sheet shows that the firm has $405.19M in Cash & Short Term Investments as of fiscal 2021. There were $99.73M in debt and $225.50M in liabilities at the time. Its Book Value Per Share was -$1.60, while its Total Shareholder’s Equity was $229.11M.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FGEN is Buy with a score of 2.40.